Kymera Therapeutics, Inc (KYMR) insider trading
Every open-market stock purchase and sale by Kymera Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Nello Mainolfi (CEO) and 1 other sold $4.2M in the last 90 days.
- Last insider buy: Baker Bros. Advisors LP (Insider), $158M, 10 months ago.
Last 12 months: insiders bought $172M (1 buy) and sold $475M (44 sales). Last close $112.63 on Oct 21, 2026.
Recent KYMR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | Nello Mainolfi (CEO) | Sold | $950K |
| Oct 1, 2026 | Nello Mainolfi (CEO) | Sold | $870K |
| Oct 1, 2026 | Nello Mainolfi (CEO) | Sold | $619K |
| Oct 1, 2026 | Nello Mainolfi (CEO) | Sold | $552K |
| Oct 1, 2026 | Nello Mainolfi (CEO) | Sold | $393K |
| Oct 1, 2026 | Nello Mainolfi (CEO) | Bought (not open market) | $62.4K |
| Oct 1, 2026 | Nello Mainolfi (CEO) | Sold | $30.4K |
| Oct 1, 2026 | Nello Mainolfi (CEO) | Bought (not open market) | — |
| Sep 4, 2026 | Brian Adams (C-suite exec) | Sold | $353K |
| Sep 4, 2026 | Brian Adams (C-suite exec) | Sold | $251K |
| Sep 4, 2026 | Brian Adams (C-suite exec) | Sold | $140K |
| Jul 27, 2026 | Terence Rooney (C-suite exec) | Bought (not open market) | — |
| Jul 27, 2026 | Terence Rooney (C-suite exec) | Bought (not open market) | — |
| Jul 7, 2026 | Nello Mainolfi (CEO) | Sold | $6M |
| Jul 7, 2026 | Nello Mainolfi (CEO) | Bought (not open market) | $104K |
| Jul 7, 2026 | Nello Mainolfi (CEO) | Bought (not open market) | — |
| Jul 7, 2026 | Nello Mainolfi (CEO) | Bought (not open market) | — |
| Jul 1, 2026 | Nello Mainolfi (CEO) | Sold | $5.1M |
| Jul 1, 2026 | Nello Mainolfi (CEO) | Sold | $2.8M |
| Jul 1, 2026 | Nello Mainolfi (CEO) | Sold | $755K |
| Jul 1, 2026 | Nello Mainolfi (CEO) | Sold | $389K |
| Jul 1, 2026 | Noah Goodman (C-suite exec) | Sold | $387K |
| Jul 1, 2026 | Nello Mainolfi (CEO) | Sold | $212K |
| Jul 1, 2026 | Nello Mainolfi (CEO) | Bought (not open market) | $166K |
| Jul 1, 2026 | Nello Mainolfi (CEO) | Bought (not open market) | — |
Who's trading KYMR
- Nello Mainolfi, CEO: sold $36.8M (26 sales), last Oct 1, 2026
- Brian Adams, C-suite exec: sold $744K (3 sales), last Sep 4, 2026
- Terence Rooney, C-suite exec: other filings, last Jul 27, 2026
- Noah Goodman, C-suite exec: sold $2M (8 sales), last Jul 1, 2026
- Bruce N. Jacobs, CFO: sold $10M (15 sales), last Jun 30, 2026
- Bruce Booth, Insider: sold $226M (160 sales), last Jun 29, 2026
- Bvf Partners L P/il, Director: sold $174M (4 sales), last Jun 26, 2026
- Victor Sandor, Insider: other filings, last Jun 24, 2026
- Pamela Esposito, Insider: sold $3.1M (12 sales), last Jun 24, 2026
- Baker Bros. Advisors LP, Insider: bought $172M (2 buys), last Jun 24, 2026
- Gorjan Hrustanovic, Insider: other filings, last Jun 24, 2026
- John Maraganore, Insider: other filings, last Jun 24, 2026
- Elena Ridloff, Insider: sold $1.3M (4 sales), last Jun 24, 2026
- Jeffrey W. Albers, Insider: sold $449K (2 sales), last Jun 24, 2026
- Jeremy G Chadwick, COO: sold $15.6M (29 sales), last May 27, 2026
Get free alerts when an insider at Kymera Therapeutics, Inc files a new trade →